Literature DB >> 6060954

Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.

D E Schteingart, J W Conn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6060954     DOI: 10.1210/jcem-27-12-1657

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  10 in total

1.  Treatment of an adrenal cortical carcinoma with a combination of o,p'-DDD and aminoglutethimide.

Authors:  R D Scott
Journal:  Postgrad Med J       Date:  1975-01       Impact factor: 2.401

Review 2.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

Review 3.  Medical therapy of Cushing's disease.

Authors:  Lynnette K Nieman
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 4.  Aminoglutethimide: a "side-effect" turned to therapeutic advantage.

Authors:  S W Hughss; D M Burley
Journal:  Postgrad Med J       Date:  1970-07       Impact factor: 2.401

5.  Fluctuating Cushing's syndrome, acute psychosis, aminoglutethimide therapy.

Authors:  I G Barnett; J D Nabarro; L P LeQuesne
Journal:  Proc R Soc Med       Date:  1970-04

Review 6.  Could aminoglutethimide replace adrenalectomy?

Authors:  A L Harris
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 7.  Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.

Authors:  P E Lønning; S Kvinnsland
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 8.  Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate.

Authors:  Jens Heyn; Carolin Geiger; Christian L Hinske; Josef Briegel; Florian Weis
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

Review 9.  Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.

Authors:  R J Santen
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

Review 10.  Systemic therapy of Cushing's syndrome.

Authors:  Niels Eckstein; Bodo Haas; Moritz David Sebastian Hass; Vladlena Pfeifer
Journal:  Orphanet J Rare Dis       Date:  2014-08-05       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.